Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
Introduction The Coronavirus Disease 2019 (COVID-19) pandemic has caused devastating human and economic costs. Vaccination is an important step in controlling the pandemic. Severe acute respiratory coronavirus-2 (SARS-CoV-2), the causative agent of COVID-19, infects cells by binding a cellular recep...
Saved in:
Main Authors: | Xiaoqing Guan (Author), Yang Yang (Author), Lanying Du (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain
by: Ping-Han Huang, et al.
Published: (2021) -
Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection
by: Yufei Wang, et al.
Published: (2017) -
Lactoferrin Binds through Its N-Terminus to the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
by: Patrik Babulic, et al.
Published: (2024) -
Inhibition Ability of Natural Compounds on Receptor-Binding Domain of SARS-CoV2: An In Silico Approach
by: Miroslava Nedyalkova, et al.
Published: (2021) -
A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants
by: Shugang Qin, et al.
Published: (2023)